{
  "company_name": "SUNPHARMA LTD",
  "extracted_text": "No significant corporate developments for SUNPHARMA Ltd on 24.08.2025 . Corporate news found from nearby dates includes:\n\nOn August 26, 2025, a foreign brokerage downgraded Sun Pharma's stock, citing risks to premium valuations and slower-than-expected execution in its specialty business.\n\nAn analyst/institutional investor meeting was scheduled for August 25, 2025.\n\nOn August 19, 2025, it was reported that Sun Pharma had issued a Class II recall for its Spironolactone tablets in the US due to contamination.",
  "links_raw": "1. https://www.business-standard.com/markets/capital-market-news/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks-125082600769_1.html#:~:text=Sun%20Pharma%20drops%20as%20foreign,Q1%20FY26%20over%20Q1%20FY25.\n2. https://www.business-standard.com/markets/capital-market-news/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks-125082600769_1.html#:~:text=Sun%20Pharma%20drops%20as%20foreign%20broker%20downgrades%20on%20valuation%2C%20execution%20risks,-Advertisement&text=Sun%20Pharmaceutical%20Industries%20slipped%203.08,818%20crore%20during%20the%20quarter.\n3. https://economictimes.indiatimes.com/sun-pharmaceutical-industries-ltd/stocksupdate/companyid-9134.cms#:~:text=Market%20Watch,II%20recalls%20by%20the%20USFDA.\n4. https://economictimes.indiatimes.com/vedanta-ltd/stocksupdate/companyid-13111.cms#:~:text=The%20record%20date%20for%20determining,August%2019%20to%20August%2023.&text=Markets%20rallied%20strongly%2C%20with%20Vedanta,funds%20for%20its%20capex%20plan.&text=Metal%20major%20Vedanta's%20board%20of,dividend%20on%20Wednesday%2C%20August%2027.&text=Please%20refer%20the%20enclosed%20file.,-Closure%20of%20Trading&text=Please%20refer%20the%20enclosed%20file.,-Board%20Meeting%20Intimation&text=Vedanta%20Ltdhas%20informed%20BSE%20that,Please%20refer%20the%20enclosed%20file.&text=Please%20refer%20enclosed%20file.,-Intimation%20Under%20Regulation&text=Please%20refer%20the%20enclosed%20file.,-Announcement%20under%20Regulation&text=Please%20refer%20the%20enclosed%20file.,-Disclosure%20Under%20Regulation&text=Please%20refer%20the%20enclosed%20file.,-Vedanta%20continues%20winning\n5. https://www.business-standard.com/markets/news/sun-pharma-slips-5-in-2-days-nears-52-wk-low-why-drug-stock-trades-weak-125082800326_1.html#:~:text=What's%20driving%20the%20selloff%20in,per%20cent%20during%20the%20period.\n6. https://www.capitalmarket.com/markets/news/newsdetails.aspx?sectionname=hot-pursuit&heading=sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks&sno=1633322\n7. https://htsyndication.com/capital-market/article/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation%2C-execution-risks/92717628#:~:text=Sun%20Pharma%20drops%20as%20foreign%20broker%20downgrades,valuations%20and%20slower%2Dthan%2Dexpected%20traction%20in%20speciality%20drugs.",
  "processed_links": [
    "https://1. https://www.business-standard.com/markets/capital-market-news/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks-125082600769_1.html#:~:text=Sun%20Pharma%20drops%20as%20foreign",
    "https://Q1%20FY26%20over%20Q1%20FY25.\n2. https://www.business-standard.com/markets/capital-market-news/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks-125082600769_1.html#:~:text=Sun%20Pharma%20drops%20as%20foreign%20broker%20downgrades%20on%20valuation%2C%20execution%20risks",
    "https://-Advertisement&text=Sun%20Pharmaceutical%20Industries%20slipped%203.08",
    "https://818%20crore%20during%20the%20quarter.\n3. https://economictimes.indiatimes.com/sun-pharmaceutical-industries-ltd/stocksupdate/companyid-9134.cms#:~:text=Market%20Watch",
    "https://II%20recalls%20by%20the%20USFDA.\n4. https://economictimes.indiatimes.com/vedanta-ltd/stocksupdate/companyid-13111.cms#:~:text=The%20record%20date%20for%20determining",
    "https://August%2019%20to%20August%2023.&text=Markets%20rallied%20strongly%2C%20with%20Vedanta",
    "https://funds%20for%20its%20capex%20plan.&text=Metal%20major%20Vedanta's%20board%20of",
    "https://dividend%20on%20Wednesday%2C%20August%2027.&text=Please%20refer%20the%20enclosed%20file.",
    "https://-Closure%20of%20Trading&text=Please%20refer%20the%20enclosed%20file.",
    "https://Please%20refer%20the%20enclosed%20file.&text=Please%20refer%20enclosed%20file.",
    "https://-Intimation%20Under%20Regulation&text=Please%20refer%20the%20enclosed%20file.",
    "https://-Announcement%20under%20Regulation&text=Please%20refer%20the%20enclosed%20file.",
    "https://-Disclosure%20Under%20Regulation&text=Please%20refer%20the%20enclosed%20file.",
    "https://-Vedanta%20continues%20winning\n5. https://www.business-standard.com/markets/news/sun-pharma-slips-5-in-2-days-nears-52-wk-low-why-drug-stock-trades-weak-125082800326_1.html#:~:text=What's%20driving%20the%20selloff%20in",
    "https://per%20cent%20during%20the%20period.\n6. https://www.capitalmarket.com/markets/news/newsdetails.aspx?sectionname=hot-pursuit&heading=sun-pharma-drops-as-foreign-broker-downgrades-on-valuation-execution-risks&sno=1633322\n7. https://htsyndication.com/capital-market/article/sun-pharma-drops-as-foreign-broker-downgrades-on-valuation%2C-execution-risks/92717628#:~:text=Sun%20Pharma%20drops%20as%20foreign%20broker%20downgrades",
    "https://valuations%20and%20slower%2Dthan%2Dexpected%20traction%20in%20speciality%20drugs."
  ],
  "date": "2025-08-24"
}